Study to Evaluate Suprachoroidally Administered CLS-AX in the Treatment of Neovascular Age-Related Macular Degeneration
Clinical trial NCT05891548 · COMPLETED
Trial details
- NCT number
- NCT05891548
- Sponsor
- Clearside Biomedical, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-31
- Primary completion
- 2024-08-20
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.